From: Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa
Cost-effectiviness analysis with the three different estimated 'recourse to malaria chemoprophylaxis' | 55% | 68.70% | 82.40% | |||
---|---|---|---|---|---|---|
Current situation of no reimbursement | 80% reimbursement strategy | Current situation of no reimbursement | 80% reimbursement strategy | Current situation of no reimbursement | 80% reimbursement strategy | |
Estimated number of travellers from Switzerland to West Africa | 70'000 | |||||
Cost per year (€) likliest | 4'581'654 | 3'565'716 | 3'503'346 | 3'175'326 | 2'425'038 | 2'784'936 |
Effect per year likliest | ||||||
Malaria cases | 837 | 438 | 624 | 346 | 410 | 254 |
Malaria-related deaths | 10 | 5 | 7 | 4 | 5 | 3 |
Effectiveness of 80% reimbursement strategy | ||||||
Malaria cases prevented | - | 399 | - | 278 | - | 156 |
Malaria-related deaths prevented | - | 5 | - | 3 | - | 2 |